As previously mentioned, IL-32 stimulates the production of various inflammatory mediators through the NF-κB and p38 MAPK pathways and has an important role in the progression of various inflammatory disorders such as RA and IBD [22,23]. Here, NFKB1 is linked to inflammatory bowel disease.